BiotechTube

PEG-somatropin

Phase 3Completed
0 watching 0 views this week📈 Rising
77
Hype Score

Development Stage

✓
Pre-clinical
✓
Phase 1
✓
Phase 2
4
Phase 3
5
Approved
Indication / Disease

Growth Hormone Deficiency

Conditions

Growth Hormone Deficiency

Trial Timeline

Mar 1, 2007 → Mar 1, 2008

NCT ID
NCT01495468

About PEG-somatropin

PEG-somatropin is a phase 3 stage product being developed by Sun Pharmaceutical for Growth Hormone Deficiency. The current trial status is completed. This product is registered under clinical trial identifier NCT01495468. Target conditions include Growth Hormone Deficiency.

Hype Score Breakdown

Clinical
27
Activity
18
Company
10
Novelty
9
Community
10

Clinical Trials (2)

NCT IDPhaseStatus
NCT03249480ApprovedUNKNOWN
NCT01495468Phase 3Completed

Competing Products

20 competing products in Growth Hormone Deficiency

See all competitors
ProductCompanyStageHype Score
SomatropinEli LillyPhase 3
77
Somatropin (recombinant deoxyribonucleic acid [rDNA] origin)Eli LillyPre-clinical
23
HER3-DXdDaiichi SankyoPre-clinical
23
ErlotinibAstellas PharmaPhase 2
52
radio-labeled naquotinib + naquotinibAstellas PharmaPhase 1
33
pegylated Somatropin + pegylated Somatropin + Jintropin AQSun PharmaceuticalPhase 2
52
PEG-somatropinSun PharmaceuticalApproved
85
PEG-somatropin + PEG-somatropinSun PharmaceuticalApproved
85
Somatropin + SomatropinEli LillyPhase 3
77
Somatropin + SomatropinEli LillyPhase 3
77
somatropin, rDNA origin, for injectionEli LillyPhase 3
77
Sterile becaplermin gel vs. sterile placebo gel treatment 1Johnson & JohnsonPre-clinical
23
ABT-414AbbViePre-clinical
23
Saizen® A + Saizen® BMerckPhase 3
77
Saizen® solution for injection (referred as Saizen®)MerckApproved
85
Cetuximab + FOLFIRI (5-Fluorouracil, Folinic acid, Irinotecan)MerckPhase 3
77
Saizen + SaizenMerckApproved
85
MiransertibMerckPhase 2
52
MiransertibMerckPhase 1/2
41
ARX201 + ARX201 + ARX201MerckPhase 2
52

Other Products from Sun Pharmaceutical

Ilumya Injectable ProductApproved
85
CequaTM (Cyclosporine 0.09%) ophthalmic solutionApproved
85
Cyclosporine + Artificial tearApproved
85
AmifostineApproved
85
Ilaprazole antisecretory drug of each quadruple therapy the Ilaprazole -based quadruple therapy + Esoprazole antisecretory drug of each quadruple therapy Esoprazole-based quadruple therapyApproved
85